Validation of Open organ on chip Technology for End user applications
Organ-on-Chips, and more general microphysiological systems, are believed to revolutionize the way we develop drugs or select personalized therapies. Recapitulating human response both from healthy and diseased individuals potenti...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto open-TOP
Duración del proyecto: 26 meses
Fecha Inicio: 2020-06-17
Fecha Fin: 2022-08-31
Líder del proyecto
UNIVERSITEIT TWENTE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
150K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Organ-on-Chips, and more general microphysiological systems, are believed to revolutionize the way we develop drugs or select personalized therapies. Recapitulating human response both from healthy and diseased individuals potentially even enables ‘clinical trials in-a-dish’. While research in this field is thriving and commercial start-ups have been founded, adoption from end users is staying behind due to a number of reasons: i) lack of standardization making chips not compatible with each other, ii) lack of automation which limits the throughput and user-friendliness of the systems and iii) lack of support for sensor integration. The Twente Organ-on-Chip Platform (TOP) is designed to overcome these hurdles and has been developed for internal use during the ERC project VESCEL. During interaction with other researchers and companies within the Organ-on-Chip field they expressed their interest in a more standardized, automated platform that also supports sensor integration. Since it would require a number of steps for them to be able to use the platform in their existing environment we here suggest the ‘open-TOP’ ERC Proof of Concept project where we aim to commercialize the application of the Twente Organ-on-Chip Platform (TOP) and facilitate end users to use TOP in real world contexts. To reach this objective we need to develop a robust interconnect, validate and identify difficulties in making a third party chip TOP-compatible, validate the use of TOP for a biological experiment and finally determine the commercialization strategy for TOP. We believe TOP can help more end users to adopt Organ-on-Chip as a technology in their lab because in contrast to current setups, the open technology of TOP supports chips from third parties are inter compatible, multiplexable and controlled automatically. If ‘open-TOP’ is granted, TOP will be the standardized Organ-on-Chip infrastructure allowing users to stop worrying about control systems and only focus on chips and biology.